Nitrate - Clopidogrel - Acute Coronary Syndrome
Launched by BURSA POSTGRADUATE HOSPITAL · Mar 13, 2025
Trial Information
Current as of July 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diagnosed with non-STEMI
- • Patients aged 18 to 75 years
- • positive troponin levels,
- • blood pressure above 120/70 mmHg
- Exclusion Criteria:
- • Hemodynamically unstable and requiring urgent intervention,
- • ST elevation on electrocardiography, atrial fibrillation,
- • recurrent angina,
- • use of narcotic analgesics (e.g., morphine), nitrates and glycoprotein IIb/IIIa inhibitors during hospitalization,
- • history of coronary artery bypass graft (CABG) surgery,
- • active infection,
- • uncontrolled hypertension,
- • diabetes, cerebrovascular accident, Use P2Y12 inhibitor, proton pump inhibitor, oral anticoagulant, statin, CYP enzyme-inducing or inhibiting drugs at the time of admission,
- • active systemic disease (e.g., malignancy, thyroid disorders chronic inflammatory diseases, liver dysfunction),
- • left ventricular systolic dysfunction (ejection fraction \<50%),
- • glomerular filtration rate \<60 mL/min/1.73m2,
- • allergy to ASA or clopidogrel, coagulopathy,
- • platelet counts below 100,000/μl and hematocrit levels below 29%, or exceeding 52%.
About Bursa Postgraduate Hospital
Bursa Postgraduate Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and scientific integrity, the hospital collaborates with renowned researchers and medical professionals to conduct a diverse range of trials across various therapeutic areas. By fostering a multidisciplinary approach and utilizing state-of-the-art facilities, Bursa Postgraduate Hospital aims to contribute to the development of new treatments and enhance the understanding of complex medical conditions, ultimately benefiting the broader community and advancing the field of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bursa, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported